Certain diabetes drugs linked to lower risk of kidney stones and gout

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada published by BMJ.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup